CKD Bio

CKD Bio Current Assets

The Current Assets of CKD Bio (063160.KS) as of Oct 19, 2026 is 96.77 B KRW. In the previous year, Current Assets was 111.80 B KRW — a change of -13.45% (lower).

Current Assets

96.77 BKRW

YoY

-13.45%

Last updated:

Current Assets of CKD Bio is 2025 96.77 B KRW. Current Assets of CKD Bio was 2024 111.80 B KRW. It decreases by -13.45% lower compared to the previous year.

The CKD Bio Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
60.80 B KRW
Jan 1, 2019
75.19 B KRW
Jan 1, 2020
86.52 B KRW
Jan 1, 2021
100.32 B KRW
Jan 1, 2022
110.33 B KRW
Jan 1, 2023
103.19 B KRW
Jan 1, 2024
111.80 B KRW
Jan 1, 2025
96.77 B KRW
The CKD Bio Current Assets history
YEARCurrent AssetsYoY
96.77 BKRW-13.45%
111.80 BKRW+8.35%
103.19 BKRW-6.47%
110.33 BKRW+9.97%
100.32 BKRW+15.96%
86.52 BKRW+15.06%
75.19 BKRW+23.68%
60.80 BKRW-1.94%
62.00 BKRW-11.89%
70.37 BKRW+109.44%
33.60 BKRW-45.70%
61.87 BKRW-6.19%
65.95 BKRW+5.83%
62.32 BKRW-23.13%
81.07 BKRW+21.30%
66.83 BKRW+32.18%
50.56 BKRW+4.20%
48.52 BKRW+12.30%
43.21 BKRW-10.85%
48.47 BKRW-8.85%
53.17 BKRW+14.04%
46.63 BKRW-11.76%
52.84 BKRW-25.61%
71.03 BKRW+34.73%
52.72 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

CKD Bio Stock analysis

What does CKD Bio do? CKD Bio Corp, headquartered in Seoul, South Korea, operates in the Health Care sector, specializing in pharmaceuticals. The company develops and manufactures active pharmaceutical ingredients, including antibiotic components like DMCTs and rifampicins, immunosuppressive agents such as cyclosporin and tacrolimus, and diabetes remedies like acarbose. Products are distributed domestically and internationally across markets in America, China, Europe, Africa, Southeast Asia, Latin America, and the Middle East. Listed on 11 December 2001. CKD Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CKD Bio stock

Current Assets of CKD Bio is 96.77 B KRW in 2025.

Current Assets of CKD Bio changed from 111.80 B KRW to 96.77 B KRW, representing a -13.45% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets CKD Bio since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's CKD Bio historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — CKD Bio

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — CKD Bio